In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Leveraging Healthcare Intelligence to increase diversity of oncology clinical trials
This article in the Clinical Oncologist Daily, provides as overview on leveraging healthcare intelligence to increase diversity of oncology clinical trials.
-
Navigating oncology development decisions for long-term success
In this media article, ICON expert Tanja Obradovic, PhD, highlights how mapping clear inflection points for data-driven decisions will inform efficient drug development.
-
Paediatric clinical trials for obesity treatment
In this article, ICON experts Alan Baldridge and Heather Peterson discuss the prevalence of paediatric obesity and assess clinical trials of its treatments.
-
One direction
In this piece from PharmaTimes, Connie Inguanti, President at Symphony Health, an ICON plc company, discusses shaping a culture that allows customers to embrace an abundance of pivotal data.
-
.jpg?w=545&itok=Xwb6tA5Q "EPR in healthcare news.")
Pharma Horizons: Cell and Gene Therapy
In this report, experts in the field including ICON's Patricia Fox Anderson and Emily Merrell explore some of the latest innovations in the cell and gene therapy space, from development and quality control, through to manufacturing and clinical trials.
-
Current state of drug development, clinical trials and precision measures
This article in the Journal of mHealth, provides an overview of a recent npj Nature publication, that proposes enough alignment exists between independent traditional COA and DHT libraries to build a single framework for researchers to identify and compare actively-collected versus passively-monitored tools for the same or similar measure. Article is by Caprice Sassano, Research Lead – Applied Sciences at HumanFirst, an ICON company, with collaboration from Dr. Roya Sherafat, Scientific Director, MAPI Research Trust and Marcelo Alves Favaro, Associate Outcomes Researcher, MAPI Research Trust.
-
Making the most of biodata in remote studies
In this piece, Rosie Abbott explores how advances in technology have opened up many new opportunities and challenges in research, including the collection of biodata in remote studies. (see page 9)
-
ICON experts tackle specialty drug access challenges at AXS24
In this article, Angela Lawrence, Senior Director of RWE, Joe Brown, Principal Medical and Market Research, and Mark McCoy, RPh, MBA, Director Market Access and Reimbursement discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
-
ICON interview: Insights on the new EMA guidelines for computerised systems and electronic data in clinical trials
Outsourcing Pharma spoke to Vesta Marciulioniene, director global regulatory clinical services at ICON Biotech, who shares her insights on the new EMA guideline for computerised systems and electronic data in clinical trials and what new expectations it sets for the clinical research industry.
-
Overcoming challenges with maternal vaccine trials
In this article from pharmaphorum, Dinah Knotts, VP of Project Management in Vaccines and Infectious Diseases and Mitsu Rana, Senior Director of Project Management outline some of the challenges with maternal vaccine trials and how with careful planning and execution by researchers, these can be overcome throughout the trial process.
.jpg?w=340&itok=0KGvj3Hq "EPR in healthcare news."){kind=icon}
